Thus, this study suggests unexpected roles of basal autophagy flux or NRF2 activation that has a profound impact on the regulation of the nuclear receptor FXR signaling, which could be harnessed to treat bile acid-associated metabolic diseases. The gene discussed is NFE2L2; the disease is metabolic disease.